BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3501277)

  • 1. Proteinase-inhibitor activity in sera of patients with carcinoma of the cervix uteri.
    Benítez-Bribiesca L; Freyre-Horta R; Villalobos-Ramírez M; Pastrana L
    Arch Invest Med (Mex); 1987; 18(3):187-92. PubMed ID: 3501277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythrocyte changes in cervix neoplasms and its preliminary stages].
    Linke A; Kruschwitz S; Gemende I; Männchen E; Fehse KH; Voss J
    Z Arztl Fortbild (Jena); 1977 Mar; 71(5):236-9. PubMed ID: 868103
    [No Abstract]   [Full Text] [Related]  

  • 3. Protease and antiprotease concentrations in serum and vaginal fluid of patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G
    Arch Invest Med (Mex); 1980; 11(4):523-45. PubMed ID: 7011240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of HPV infection and the level of ascorbic acid in serum of women with cervix dysplasia].
    Kwaśniewska A; Tukendorf A; Semczuk M
    Med Dosw Mikrobiol; 1996; 48(3-4):183-8. PubMed ID: 9182140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accompanying histological changes in the cervix uteri in carcinoma in situ and early invasive carcinoma].
    Krizanac S; Jukić S; Bolanca M
    Lijec Vjesn; 1987; 109(11-12):418-21. PubMed ID: 3695790
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma reduced and total ascorbic acid in human uterine cervix dysplasias and cancer.
    Romney SL; Basu J; Vermund S; Palan PR; Duttagupta C
    Ann N Y Acad Sci; 1987; 498():132-43. PubMed ID: 3475995
    [No Abstract]   [Full Text] [Related]  

  • 7. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
    Ishiguro T; Sugitachi I; Katoh K
    Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
    [No Abstract]   [Full Text] [Related]  

  • 8. Copper and zinc levels in serum from patients with abnormalities of the uterine cervix.
    Grail A; Norval M
    Acta Obstet Gynecol Scand; 1986; 65(5):443-7. PubMed ID: 3776486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Round table: Carcinoma of the cervix uteri].
    Escudero P; Saavedra R; Martínez L; Salas O; Morales E; González J
    Rev Chil Obstet Ginecol; 1982; 47(1):30-45. PubMed ID: 6927318
    [No Abstract]   [Full Text] [Related]  

  • 11. Cathepsin B and antiproteases in patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G; de la Huerta-Sánchez R; Alfaro-Aceves L
    Arch Invest Med (Mex); 1981; 12(4):517-37. PubMed ID: 7332393
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody levels against alpha-galactosyl epitopes in sera of patients with squamous intraepithelial lesions and early invasive cervical carcinoma.
    Tremont-Lukats IW; Avila JL; Hernández D; Vásquez J; Teixeira GM; Rojas M
    Gynecol Oncol; 1997 Feb; 64(2):207-12. PubMed ID: 9038265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryosurgery for dysplasia, carcinoma in situ, and microinvasive carcinoma of the uterine cervix (author's transl)].
    Kashimura M; Taki I
    Acta Obstet Gynaecol Jpn; 1981 May; 33(5):635-42. PubMed ID: 7234351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and treatment problems and prospects in precancerous and early stages of cervical cancer].
    Karag'ozov A
    Akush Ginekol (Sofiia); 1981; 20(4):331-7. PubMed ID: 7030097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rapidly-appearing carcinoma in situ and invasive cancer of the cervix].
    Beuret T; Sadoul G; Barbagelatta M; de Brux J
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(2):147-54. PubMed ID: 6863864
    [No Abstract]   [Full Text] [Related]  

  • 16. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
    Nagai N; Oshita T; Murakami J; Ohama K
    Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytofluorimetric research on the epithelium of the cervix uteri in malignancy].
    Ganina KP; Nosa PP; Boroda AN; Klevetenko MP
    Tsitol Genet; 1993; 27(2):30-7. PubMed ID: 8212323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteinase levels, platelet functional and morphological alterations in patients with cervix uteri carcinoma. Correlation with the degree of progression of the malignancy.
    Benítez-Bribiesca L; Villanueva C; Freyre R; Amezcua JL; de la Huerta R; Luévano E; Pastrana L
    Arch Invest Med (Mex); 1986; 17(2):211-42. PubMed ID: 3109344
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of cancer cervix by estimation of sialic acid.
    Roy A; Chakraborty S
    J Indian Med Assoc; 2005 Nov; 103(11):589-90. PubMed ID: 16570760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histology of premalignant changes in the cervix uteri].
    Torhorst J
    Gynakologe; 1981 Dec; 14(4):199-203. PubMed ID: 7033079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.